28 marzo 2015
Overall survival for women who received standard chemotherapy treatment plus bevacizumab was a median five months longer than for women who received the standard chemotherapy treatment alone.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/WBvCCHg-EUc/150328102416.htm
